New Intravitreal Treatment for Diabetic Retinopathy - Banco de Patentes

Diabetic retinopathy is a leading cause of blindness worldwide. The present invention formulates a new intravitreal treatment that inhibits the inflammatory underlying problem that triggers the disease. It is a therapeutic option with an active ingredient which has demonstrated efficacy in experimental phase and improves the cost/ effectiveness of current treatments.